Axil Capital Partners
Tokyo, Tokyoaxilcapital.com
Overview
Axil Capital is a venture capital firm specializing in investments in the biomedical and healthcare technology sectors . It focuses on funding and supporting the growth of early-stage ventures, providing financial resources and strategic guidance . Axil invests across the full spectrum of the global biotech and healthcare space, ranging from seed to crossover stage venture capital opportunities . They diversify their investments across a wide range of technologies in the life science field, including biopharmaceuticals, platform technologies, medical devices, digital health and healthcare services .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Fore Biotherapeutics | Jul 2026 | Series D-2 Extension | Co-investor |
| LinqMed Inc. | Jan 2025 | Series B | Co-investor |
| Cellusion Inc. | Jun 2023 | Series C | Lead |
| LUCA Science | Aug 2020 | Series A | Lead |
| Himuka AM Pharma Corp. | Jun 2018 | Series A | Co-investor |
Key People
Yoshitake Maeda
Venture Partner
Joon Paek
Principal
Kimihito Usui
Senior Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.